| Richard Bienvenu, | |
|
6765 Corporate Blvd, Apt 9209, Baton Rouge, LA 70809-1061 | |
| (225) 923-9781 | |
| Not Available |
| Full Name | Richard Bienvenu |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 6765 Corporate Blvd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306200308 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 016416 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard Bienvenu, 6765 Corporate Blvd, Apt 9209, Baton Rouge, LA 70809-1061 Ph: (225) 923-9781 | Richard Bienvenu, 6765 Corporate Blvd, Apt 9209, Baton Rouge, LA 70809-1061 Ph: (225) 923-9781 |
News Archive
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
Many surgical patients don't know that it's advisable to stop taking complementary and alternative medicine at least one to three weeks prior to surgery. During Patient Safety Awareness Week, March 13-19, 2016, the American Association of Nurse Anesthetists is reminding patients to bring a list of all medications - prescription or not - to their pre-anesthesia interview, and to share details about their medication use with their Certified Registered Nurse Anesthetist or other anesthesia professional.
S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.
The Washington Post offers a look at how hospital and physician lobbyists adamantly fought the Medicare buy-in proposal, which would have allowed people age 55 to 64 to buy Medicare coverage. Such efforts led to the proposal's disappearance within six days.
› Verified 8 days ago
Mr. Kenneth W. Howie, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7515 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-6084 Fax: 225-767-7300 | |
Mrs. Sharon Ann Alcorn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4485 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-926-0734 | |
Sonya Bremer Boss, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3239 Riverwalk Dr, Baton Rouge, LA 70820 Phone: 225-281-1475 Fax: 225-578-7163 | |
Norman Francise, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10974 Joor Rd, Baton Rouge, LA 70818 Phone: 225-261-4530 | |
Paul Antoine Bordelon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6920 Plank Rd, Baton Rouge, LA 70811 Phone: 225-356-0654 | |
Ms. Jennifer Leane Simpson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10974 Joor Rd, Baton Rouge, LA 70818 Phone: 225-261-4530 Fax: 225-261-1622 | |
Charles Joseph Paradelas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7411 Florida Blvd, Baton Rouge, LA 70806 Phone: 225-928-8982 Fax: 225-928-8986 |